Advertisement

Topics

Phase 2 Discovery, Inc. Company Profile

12:42 EDT 25th September 2018 | BioPortfolio

Phase 2 Discovery (P2D) is a pharmaceutical company focused on developing innovative drugs that fulfill unmet medical needs in the treatment of central nervous system (CNS) disorders such as insomnia, anxiety, depression, attention disorders and neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).
At P2D, we are using our understanding of the treatment of CNS disorders and neurodegenerative diseases and our experienced team to efficiently build a product portfolio of therapeutics with a greater likelihood for clinical success. Our goal is to advance a product candidate through clinical proof of concept by producing powerful and compelling clinical data and then seeking partners to complete development and commercialization.

Location

3130 Highland Ave
Cincinnati
Ohio
45219
United States of America

Contact

Phone: (513) 475-6618
Fax: (513) 221-1891
Email: jmulchahey@phase2D.com


News Articles [1226 Associated News Articles listed on BioPortfolio]

Candidates Targeting Parkinson's Disease and ALS Advance in Discovery Phase

June 27, 2018 (Investorideas.com Newswire) This precision medicine company, focused on neurodegenerative diseases, has selected antibody candidates to advance into the final phase of discovery.

Sanford Burnham Prebys compound advances into Phase 1 trial for pancreatic cancer

(Sanford Burnham Prebys Medical Discovery Institute) A compound discovered at Sanford Burnham Prebys Medical Discovery Institute (SBP) has advanced into a Phase 1 trial for metastatic pancreatic cance...

WuXi AppTec and Cyclica team to drive polypharmacology in drug discovery

The multi-phase collaboration between WuXi AppTec Research Service Division and Cyclica looks to advance polypharmacology in drug discovery using AI-augmented technology.

Irori, Afferent Link Solid Phase Synthesis Products with Combinational Chemistry Software

Irori (La Jolla, CA), a subsidiary of Discovery Partners International and a provider of drug discovery technologies, has signed a collaboration agreement with Afferent Systems Inc. (San Francisco), a...

ADC Therapeutics terminates phase I trial of ADCT─502 programme targeting HER2 expressing solid tumors

ADC Therapeutics (ADCT), an oncology drug discovery and development company, has terminated the phase I clinical trial to evaluate its antibody drug conjugate (ADC) ADCT─502 in patients with advance...

Tetra starts Phase ll Trial of BPN14770 for Fragile X Syndrome

Tetra Discovery Partners has commenced a Phase ll trial of BPN14770 for the treatment of Fragile X Syndrome, the most...Read More... The post Tetra starts Phase ll Trial of BPN14770 for Fragile X Synd...

Chimerix Announces Discovery and Demonstrated Preclinical Activity Supporting Ongoing Phase 1 Study of New Antiviral for Treatment and Prevention of Norovirus

- CMX521 is Active In Vitro Against All Strains of Norovirus Tested - - Oral Dosing of CMX521 Inhibited Norovirus Replication in Animal Model - DURHAM, N.C., June 12, 2018 (GLOBE NEWSWIRE) -- C...

Innovation Pharma (IPIX) Posts Positive Phase 2 IBD Data

Recently, Innovation Pharma (OTCMKTS:IPIX) reported positive results for its phase 2 proof of concept clinical study. The results were presented at the Drug Discovery & Therapy World Congress in B...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Caraderma [A Refreshing Discovery, Inc.]

CaraDerma acne treatment

Granisetron hydrochloride [Breckenridge Pharmaceutical, Inc.]

GRANISETRON HYDROCHLORIDE TABLETS, USP

Sprycel [E.R. Squibb & Sons, L.L.C.]

These highlights do not include all the information needed to use SPRYCEL safely and effectively. See full prescribing information for SPRYCEL. SPRYCEL (dasatinib) Tablet for Oral Use Initial U.S. App...

Temodar [Schering Corporation]

These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) CapsulesTEMODAR (temozolomide) fo...

Temodar [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) CapsulesTEMODAR (temozolomide) fo...

PubMed Articles [1871 Associated PubMed Articles listed on BioPortfolio]

The Current Status of Drug Discovery and Development as Originated in US Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.

Academic drug discovery is a vital component to current drug discovery and development environments. In this study we investigated 798 drug discovery projects that took place between 1991 and 2015 at ...

Computational Toxicology and Drug Discovery.

The use of computational toxicology methods within drug discovery began in the early 2000s with applications such as predicting bacterial mutagenicity and hERG inhibition. The field has been continuou...

Patterning-induced ferromagnetism of Fe3GeTe2 van der Waals materials beyond room temperature.

Magnetic van der Waals (vdW) materials have emerged as promising candidates for spintronics applications especially after the recent discovery of intrinsic ferromagnetism in monolayer vdW materials. T...

Discovery of Rogaratinib (BAY 1163877): a pan-FGFR Inhibitor.

Rogaratinib (BAY 1163877) is a highly potent and selective small-molecule pan-fibroblast growth factor receptor (FGFR) inhibitor (FGFR1-4) for oral application currently being investigated in phase ...

Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.

Using a non-invasive biofluid (saliva), we apply a powerful metabolomics workflow for unbiased biomarker discovery in Alzheimer's disease (AD). We profile and differentiate Cognitively Normal (CN), Mi...

Clinical Trials [1480 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Biologic Basis of Liver Cancer From Chronic Hepatitis B

The focus of the study is to identify viral factors and host immune responses that differentiate HBV-related HCC patients from HBV patients who have not progressed to HCC. To that end, the...

Companies [1883 Associated Companies listed on BioPortfolio]

ACADIA Pharmaceuticals Inc.

ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACA...

Newron Pharmaceuticals SpA

Newron Pharmaceuticals SpA is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule drugs for the treatment of central nervous system (CNS) diseases. Ou...

DOV Pharmaceutical

We are a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, cardiovascular and urological disorders...

Invicro LLC

Based in Boston, MA, Invicro was founded in 2008 with the mission of improving the role and function of imaging in translational drug discovery and development across all therapeu...

Euthymics Bioscience, Inc.

DOV is a biopharmaceutical company historically focused on the development of novel product candidates for disorders of the central nervous system. DOV has previously funded drug development and disco...

More Information about "Phase 2 Discovery, Inc." on BioPortfolio

We have published hundreds of Phase 2 Discovery, Inc. news stories on BioPortfolio along with dozens of Phase 2 Discovery, Inc. Clinical Trials and PubMed Articles about Phase 2 Discovery, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phase 2 Discovery, Inc. Companies in our database. You can also find out about relevant Phase 2 Discovery, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...


Corporate Database Quicklinks



Searches Linking to this Company Record